Teriflunomide and Betaseron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Teriflunomide (teriflunomide) and Betaseron (interferon beta-1b). Common drug interactions include pain in extremity among females and alopecia among males.

The phase IV clinical study analyzes what interactions people have when they take Teriflunomide and Betaseron. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Teriflunomide?

Teriflunomide has active ingredients of teriflunomide. eHealthMe is studying from 5,067 Teriflunomide users. Check the latest studies of Teriflunomide.

What is Betaseron?

Betaseron has active ingredients of interferon beta-1b. It is often used in multiple sclerosis. eHealthMe is studying from 26,886 Betaseron users. Check the latest studies of Betaseron.

On Jul, 13, 2026

13 people who take Teriflunomide and Betaseron together, and have interactions are studied.

Teriflunomide and Betaseron drug interactions.

What are the common drug interactions of Teriflunomide and Betaseron, by gender? *:

female:

Pain in extremity
Tremor (trembling or shaking movements in one or more parts of your body)
Alopecia (absence of hair from areas of the body)
Balance disorder
Malaise (a feeling of general discomfort or uneasiness)
Weight decreased
Fall
Hypoaesthesia (reduced sense of touch or sensation)
Decreased appetite
Encephalopathy (functioning of the brain is affected by some agent or condition)

male:

Alopecia (absence of hair from areas of the body)
Diarrhoea
Injection site reaction
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Nocturia (the need to get up in the night to urinate)
Optic neuritis (optic nerve inflammation)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pruritus (severe itching of the skin)
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
Urinary tract infection

What are the common drug interactions of Teriflunomide and Betaseron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Back pain
Depressed mood
Fall
Furuncle (infection of the hair follicle)
Hypoaesthesia (reduced sense of touch or sensation)
Jaw fracture
Pain in extremity
Pruritus (severe itching of the skin)
Rash papular (redness with papule)
Tremor (trembling or shaking movements in one or more parts of your body)

30-39:

Adverse drug reaction
Alopecia (absence of hair from areas of the body)
Anxiety
Balance disorder
Cough
Disability
Fall
Headache (pain in head)
Hypersensitivity
Hypoaesthesia (reduced sense of touch or sensation)

40-49:

Alopecia (absence of hair from areas of the body)
Diarrhoea
Dizziness
Fall
Injury
Pain in extremity
Thrombosis (formation of a blood clot inside a blood vessel)

50-59:

Decreased appetite
Malaise (a feeling of general discomfort or uneasiness)
Pain in extremity
Weight decreased
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Impaired driving ability
Injection site abscess
Injection site reaction
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)

60+:

Encephalopathy (functioning of the brain is affected by some agent or condition)
Exostosis (formation of new bone on the surface of a bone)
Hypertension (high blood pressure)
Hypotension (abnormally low blood pressure)
Intervertebral disc protrusion (spinal disc protrusion)
Nephrolithiasis (calculi in the kidneys)
Parkinson's disease
Tremor (trembling or shaking movements in one or more parts of your body)

What are the existing conditions these people have? *

Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 1 person, 7.69%
Prostatomegaly (enlargement of the prostate): 1 person, 7.69%
Incontinence (lack of moderation or self-control): 1 person, 7.69%
Ill-Defined Disorder: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Teriflunomide and Betaseron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously